Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of bioactive molecules and drug candidates. Its structure supports the construction of complex piperazine-based derivatives, which are common in medicinal chemistry for their favorable pharmacokinetic properties. Commonly employed in research settings for creating protease inhibitors, receptor agonists, or antagonists. Also utilized in the preparation of small-molecule therapeutics targeting neurological disorders and infectious diseases. Suitable for use in solid-phase and solution-phase peptide-like synthesis due to the presence of protected functional groups.